Jared Kaltwasser

Central Mexican women and women from Yucatán both had risk factors for systemic lupus erythematosus, but they differed in type and degree of risk.

Two common models, the CURB-65 and BAP-65, had low predictive value in determining which patients with pneumonic chronic obstructive pulmonary disease would not survive.

The report builds upon existing research into metabolic biomarkers, identifying 14 differential biomarkers in patients with systemic lupus erythematosus and skin involvement.

Investigators analyzed 12 categories of workplace agents, but only the composite category of pesticides was found to be linked with developing chronic obstructive pulmonary disease.

Although a number of biomarkers can be used to track features of pulmonary hypertension, no single biomarker is sufficient, according to a new review.

A lack of relationships with pulmonary rehabilitation providers and provider perceptions about patient acceptance serve as limiting factors, new research shows.

The new one-page tool can be completed about 20 minutes faster than the older form, but it is also more accurate, investigators said.

The screening tools were found to be feasible measurements and took just 7.6 minutes to complete on average.

According to a recent study, nearly 50% of patients with connective tissue disease, such as lupus, died when sepsis occurred.

Predictive markers may make it easier to figure out which patients require the often costly and invasive measures needed to confirm the coronary complication in patients with systemic lupus erythematosus.

In a small study, evidence suggested 8-Hydroxy-2'-deoxyguanosine levels negatively correlated with a test of exercise endurance.

Patients whose endurance increases will likely have a higher quality of life and ability to carry out daily functions, the authors said.

The report suggests remission and disease activity state alone are not the most important risk factors in pregnant women with well-controlled systemic lupus erythematosus.

Evidence suggests higher levels of iron in pulmonary macrophages heightens the risk of infectious exacerbations.

The research suggests a computed tomography-readable biomarker could help clinicians better understand individual cases of chronic obstructive pulmonary disease.

A new retrospective analysis proposes cutoff values that could help physicians identify patients at highest risk of severe kidney complications.

The study found 1 in 5 physicians felt acne had a negative impact on their working lives.

New evidence suggests macrophage regulation could be an important area of inquiry in systemic lupus erythematosus, but the research is in its early stages.

The 30-day readmission rate among patients receiving post-hospitalization at-home interventions was roughly half the rate of a control group.

Graft-versus-host disease (GVHD) is common, yet it is poorly understood and its symptoms can be difficult to recognize.

As noninvasive ventilation grows in popularity, new research examines when the therapy works, and when clinicians should be cautious.

The new study suggests certain sub-categories of patients are at particularly high risk.

The study points to the challenges of treating chronic obstructive pulmonary disease in a remote region in a country with a high smoking rate.

The patient had no obvious pulmonary symptoms, but a routine chest X-ray helped investigators arrive at the diagnosis.

The new research is aimed at a patient group often left out of research studies.

The new recommendations for systemic lupus erythematosus (SLE) use disease activity index scores and evaluator’s global assessment measures, but they do not include serology.

A new study comparing intensive care unit stays among patients with Parkinson disease and controls without the disease found the former have more severe illness, but both groups have similar survival rates.

A new study characterizes the rate of allergic contact dermatitis among patients given skin adhesives.

A new report finds patients with systemic lupus erythematosus and 5 other autoimmune disorders face an increased risk of gastric cancers.

A total of 92 gene variants were sequenced, 41 of which were novel.